N
NovaMed Pharmaceuticals
NovaMed Pharmaceuticals is focused on sales and marketing, register, circulation, manufacture, and R&D through virtual intergration
About NovaMed Pharmaceuticals
NovaMed Pharmaceuticals is a leading player in Pakistan's pharmaceutical industry, known for its commitment to trust, excellence, and quality. The company specializes in manufacturing a wide range of innovative and high-quality medicines, catering to both national and multinational companies. NovaMed operates in various therapeutic classes and offers products in diverse dosage forms. The company's business model includes toll manufacturing arrangements, where it partners with renowned local and international companies to produce their pharmaceutical products. This model allows NovaMed to generate revenue through manufacturing contracts and export sales. NovaMed's products are available in Pakistan and several export markets, reflecting its global presence. The company holds several certifications, including ISO 9001:2000, ISO 22000, IS 14000, and CE marking for Tulle, as well as WHO cGMP Pakistan and GMP Nigeria certifications. These certifications underscore NovaMed's commitment to maintaining high manufacturing standards. NovaMed serves a diverse clientele, including 250 satisfied toll partners and 15,000 happy customers, and exports to 8 countries. The company's focus on quality control, research and development, and quality assurance ensures that it continues to meet the needs of its clients and maintain its reputation for excellence.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Apr 2011 | $105M | $105M | SciClone Pharmaceuticals | — |
| SERIES B✓Equity / VC | Jan 2008 | $14M | $55M | Eight Roads Ventures · Atlas Venture | — |
Growth signals
Latest recorded traffic for NovaMed Pharmaceuticals is 120 monthly website visits, down 73.9% over the last three months. NovaMed Pharmaceuticals's team declined 11.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
NovaMed Pharmaceuticals in the Baoshan District ecosystem
The NovaMed Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Other known investors2 additional known investors
SciClone Pharmaceuticals
F-Prime
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NovaMed Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NovaMed Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.












